Better spending can improve emergency medical services in Eastern Cape

Much has been reported on alleged corruption and governance failures in the Eastern Cape Health department that have devastating consequences for health services to those most in need. This is also true for inadequate Emergency Medical Services in the province. Nontsikelelo Mpulo and Thokozile Mtsolongo argue that solutions to the province’s EMS woes should start with improved spending of available budgets.

Read More

TB catch-up plan underway in WC but old challenges linger

In 2019 around 360 000 people in South Africa fell ill with tuberculosis (TB) and about 58 000 people died due to the disease, according to a World Health Organization Report released last week. The COVID-19 pandemic has exacerbated these already alarming numbers, with some TB patients stopping treatment during lockdown. Siyabonga Kamnqa looks at the plans the Western Cape Health Department has in place to get its TB programme back on track and finds old challenges still remain.

Read More

What is behind SA’s higher TB numbers?

A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.

Read More

Herd (Immunity) Today, Gone Tomorrow

There is much talk in South Africa about a ‘second wave’ of COVID-19. In Europe, it is much more than talk, with COVID-19 diagnoses, hospital admissions, and deaths, not to mention ‘restrictions’, all on the rise. Alex Welte places in perspective what we do and do not know about herd immunity and potential second waves.

Read More

IN-DEPTH: The slow motion race for a TB vaccine

In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.

Read More